Gene · 5932
Papers3,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins. | Cell Rep | 2023 | 36724073 | PubTator, text mining | PubMed |
| SUMO Proteomics Analyses Identify Protein Inhibitor of Activated STAT-Mediated Regulatory Networks Involved in Cell Cycle and Cell Proliferation. | J Proteome Res | 2023 | 36723483 | PubTator, text mining | PubMed |
| Elevated PAF1-RAD52 axis confers chemoresistance to human cancers. | Cell Rep | 2023 | 36709426 | PubTator, text mining | PubMed |
| A CRISPR-Cas9 screen identifies EXO1 as a formaldehyde resistance gene. | Nat Commun | 2023 | 36693839 | PubTator, text mining | PubMed |
| NEDD8-conjugating enzyme E2s: critical targets for cancer therapy. | Cell Death Discov | 2023 | 36690633 | PubTator, text mining | PubMed |
| The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy. | Pharmaceuticals (Basel) | 2023 | 36678591 | PubTator, text mining | PubMed |
| Recent Advances in Genome-Engineering Strategies. | Genes (Basel) | 2023 | 36672870 | PubTator, text mining | PubMed |
| DNA Damage Response and Repair in Boron Neutron Capture Therapy. | Genes (Basel) | 2023 | 36672868 | PubTator, text mining | PubMed |
| Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control. | Mol Cell | 2023 | 36669489 | PubTator, text mining | PubMed |
| Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance. | EMBO Mol Med | 2023 | 36652375 | PubTator, text mining | PubMed |
| ATM suppresses c-Myc overexpression in the mammary epithelium in response to estrogen. | Cell Rep | 2023 | 36640339 | PubTator, text mining | PubMed |
| Exploring pradimicin-IRD antineoplastic mechanisms and related DNA repair pathways. | Chem Biol Interact | 2023 | 36634904 | PubTator, text mining | PubMed |
| Multi-layered chromatin proteomics identifies cell vulnerabilities in DNA repair. | Nucleic Acids Res | 2023 | 36629267 | PubTator, text mining | PubMed |
| Resolution of sequence divergence for repeat-mediated deletions shows a polarity that is mediated by MLH1. | Nucleic Acids Res | 2023 | 36620890 | PubTator, text mining | PubMed |
| Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status. | J Ovarian Res | 2023 | 36611214 | PubTator, text mining | PubMed |
| Pol X DNA polymerases contribute to NHEJ flexibility. | Nat Struct Mol Biol | 2023 | 36587186 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing uncovers dynamic roadmap and cell-cell communication during buffalo spermatogenesis. | iScience | 2023 | 36582818 | PubTator, text mining | PubMed |
| Chromatin modifiers: A new class of pollutants with potential epigenetic effects revealed by in vitro assays and transcriptomic analyses. | Toxicology | 2023 | 36581016 | PubTator, text mining | PubMed |
| A review of protocols for brain organoids and applications for disease modeling. | STAR Protoc | 2023 | 36566384 | PubTator, text mining | PubMed |
| Chromosome-dependent aneuploid formation in Spo11-less meiosis. | Genes Cells | 2023 | 36530025 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5932/papers?page=17